Developed by Northwestern scientists, a novel skin-mounted sticker that absorbs sweat and then changes color can provide an accurate, easy-to-read diagnosis of cystic fibrosis within minutes.
Northwestern Medicine investigators have discovered that inhibiting tumor-associated myeloid cells ability to produce specialized metabolites called polyamines may improve the effectiveness of treatments for glioblastoma.
Northwestern and Lurie Children’s Hospital investigators have been approved for a $4 million funding award by the Patient-Centered Outcomes Research Institute (PCORI) to study Lennox-Gastaut Syndrome.
Northwestern Medicine investigators have identified a potential combined targeted therapy approach for treating glioblastoma, according to a recent study published in the journal Scientific Reports.
A novel wireless device may improve real-time monitoring of blood flow and oxygenation in the brain for neonatal and pediatric patients, according to a Northwestern Medicine study published in PNAS.
Nathan Shlobin, a second-year medical student, was the first author of a study recently published in the Journal of Neurosurgery, which identified through systematic review potential risk factors for spinal cord ischemia related to anterior thoracolumbar surgery.
Northwestern investigators have developed a novel vaccine that utilizes a specialized group of B-cells to promote anti-tumor immunity against glioblastoma.
A Northwestern Medicine study has demonstrated the role of dopamine in the progression of glioblastoma and suggests that targeting the neurotransmitter may slow cancer growth.
Armed with a prestigious new grant, investigators prepare to rapidly translate scientific breakthroughs into better brain tumor therapies. Read the story in Northwestern Medicine magazine.